PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Novel bispecific design improves CAR T–cell immunotherapy for childhood leukemia

Scientists at St. Jude Children’s Research Hospital improved bispecific chimeric antigen receptor (CAR) T–cell immunotherapies for acute myeloid leukemia (AML), corroborated by computational analysis

Novel bispecific design improves CAR T–cell immunotherapy for childhood leukemia
2024-02-12
(Press-News.org) (MEMPHIS, Tenn. – February 12, 2024) St. Jude Children’s Research Hospital scientists improved chimeric antigen receptor (CAR) T–cell immunotherapy for acute myeloid leukemia (AML), demonstrating better efficacy in the lab. To overcome common problems with CAR T cells, the researchers created an additional means for the therapy to find and eliminate cancer cells, using a small peptide. The study also showed how a computational approach incorporating AlphaFold predicted protein models could help understand how structure impacts antigen recognition and therapy efficacy. The findings were published today in Cell Reports Medicine.

 

Immunotherapy that reprograms a patient’s own immune cells to target a cancer-specific protein, CAR T–cell therapy, has shown success in treating some relapsed leukemias. However, sometimes the treatment is unsuccessful because cancer cells that do not have the targeted protein can still grow, escaping the therapy and causing a relapse. The relapse rate for AML is high, leading to a poor prognosis for the disease overall.

 

The St. Jude group thought it might be possible to overcome the problem of immune escape in AML models by targeting two different cancer-related proteins instead of just one. Others have attempted a similar approach but have encountered problems with the structure of the bispecific CAR. The scientists overcame these problems by adding a small peptide to the CAR to serve as the binder for the second targeted protein, then confirmed their results with computational structural analysis of their improved constructs.

 

“One of the most exciting aspects of the study is that this approach can be widely extrapolated to other tumors,” said senior corresponding author Paulina Velasquez, MD, St. Jude Department of Bone Marrow Transplantation and Cellular Therapy. “We focused on leukemia, but combining bispecific CAR design with computational predictions can be widely extrapolated for other tumors such as solid and brain tumors.”

 

Improving dual targeting by adding a second, small barcode scanner

 

The CAR the researchers created is a unique design. It is a single molecule, which includes the region of an antibody that binds a specific target (its antigen) and one short peptide that binds a separate target.

 

“The two different binding domains of the CAR are like having two barcode scanners instead of one, looking for their appropriate barcode, the targeted cancer-related proteins,” Velasquez said. “Normally, a CAR has a single barcode scanner. Here, we placed two slightly different barcode scanners on top of each other, and if either one detects an appropriate target barcode, the anti-cancer immunotherapy response activates.”

 

The two binding domains are connected by a linker to allow for the binding of two different cancer-related proteins. This differs greatly from previous dual-targeting approaches in the field, which typically used two full antibody-based binding segments.

 

“We showed the value in finding creative ways to perform dual-antigen targeting,” said first author Jaquelyn Zoine, PhD, St. Jude Department of Bone Marrow Transplantation and Cellular Therapy. “Prior bispecific CAR approaches use two antibody-based single-chain variable fragments, which are physically large molecules and can get in each other’s way, sometimes leading to poor or inefficient binding. Our approach instead added a small peptide, enabling our CAR to engage either platform to prevent immune escape.”

 

The dual-targeted CARs performed better than single-targeted CARs in both in vitro and in vivo experiments, demonstrating promise for improving CAR T–cell function.

 

Untangling two-target constructs’ performance with artificial intelligence

 

“We showed a proof of principle to explain and potentially expand the CAR design repertoire,” said co-author M. Madan Babu, PhD, FRS, St. Jude Center of Excellence for Data-Driven Discovery director, and the George J Pedersen Endowed Chair in Biological Data Science in the Department of Structural Biology. “But then comes the challenge. How do we know what linkers to choose? How do we know how much physical flexibility is needed?”

 

Since the physical structure of the targeting molecule and its linker that bridges the two binding domains can cause internal interference that prevents binding to the targets on the cancer cell, identifying what type of linkers were more common in effective therapies could lead to future improvement. Computational structure predictions and comparing structures with experimental results confirmed to the St. Jude group that shorter, more flexible linkers would work better in their models.

 

“If we have a rigid linker connecting the barcode scanners, it can only scan a restricted volume on the cancer cell, making it less effective in finding the targets,” Babu said. “We found when you have a linker of sufficient flexibility and shorter length so it doesn’t fold onto itself, it can scan a much larger volume and is more likely to find the target proteins on the cancer cell. Then you have a more effective pair of barcode scanners that work together.”

 

“We are one of few groups in the world to use AI-based structure prediction tools for CAR design,” said second author Kalyan Immadisetty, St. Jude Department of Bone Marrow Transplantation and Cellular Therapy. Immadisetty confirmed the association between short, flexible linkers and greater anti-cancer efficacy by comparing 3D-modeled structures. This information supported the performance of the CAR in real experimental outputs.

 

“We were excited that the structural predictions supported our experiments that informed us a short and flexible linker would be the best configuration,” Zoine said. “While we performed the experiments, Immadisetty found the structural components correlating almost exactly with what we were showing functionally, even when we switched one of the targeting antibody binding domains. We have now introduced the idea that these AI prediction tools can be extended to other CAR constructs.”

 

“Most importantly, others can now use our computational approach for designing their CARs,” Immadisetty said. “And hopefully, it will help them understand the efficacy of their CAR technology and lead to overall improvements for leukemia and other malignancies.”

 

Authors and funding

The study’s other authors are Jorge Ibanez-Vega, Sarah Moore, Chris Nevitt, Unmesha Thanekar, Liqing Tian, Abbas Karouni, Peter Chockley, Bright Arthur, Heather Shepphard, Jeffery Klco, Deanna Langfitt, Giedre Krenciute and Stephen Gottschalk, of St. Jude.

 

The study was supported by grants from the National Institutes of Health (P01CA096832 and R50CA211481), National Cancer Institute (P30CA021765), Assisi Foundation of Memphis and ALSAC, the fundraising and awareness organization of St. Jude.

 

If you are interested in licensing the GRP78 CAR T cell from St. Jude (SJ-19-0050) for further development and/or commercial use, find out more about licensing.

 

St. Jude Media Relations Contacts

Michael Sheffield
Desk: (901) 595-0221
Cell: (901) 379-6072
michael.sheffield@stjude.org
media@stjude.org

 

Rae Lyn Hartley

Cell: (901) 686-2597

raelyn.hartley@stjude.org

media@stjude.org

 

St. Jude Children's Research Hospital

St. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer, sickle cell disease and other life-threatening disorders. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20% to 80% since the hospital opened more than 60 years ago. St. Jude shares the breakthroughs it makes to help doctors and researchers at local hospitals and cancer centers around the world improve the quality of treatment and care for even more children. To learn more, visit stjude.org, read St. Jude Progress digital magazine, and follow St. Jude on social media at @stjuderesearch. 

 

END

[Attachments] See images for this press release:
Novel bispecific design improves CAR T–cell immunotherapy for childhood leukemia Novel bispecific design improves CAR T–cell immunotherapy for childhood leukemia 2 Novel bispecific design improves CAR T–cell immunotherapy for childhood leukemia 3

ELSE PRESS RELEASES FROM THIS DATE:

Including socioeconomic status of patients in calculation of Medicare readmission penalties would reduce stress on safety-net hospitals

2024-02-12
INDIANAPOLIS -- The Affordable Care Act requires Medicare to issue penalties that reduce payment to hospitals if post-operative readmission rates within 30 days exceed the national average. A new study led by Regenstrief Institute Research Scientist Andrew Gonzalez, M.D., J.D., MPH, reports that including socioeconomic status in the penalty calculation would reduce the amount of readmission penalties for safety-net hospitals, which typically care for the sickest patients. Other factors, including age and sex are ...

Are ammonia engines the way of the future? (video)

Are ammonia engines the way of the future? (video)
2024-02-12
WASHINGTON, Feb. 12, 2024 — Could ammonia engines power the cars of the future? Carmakers like Toyota are working to make this a reality. Ammonia is combustible and holds promise as a relatively low-effort way to decarbonize the internal combustion engine — but the devil’s in the details. Join George as he discovers at least one of those details by burning stuff in his basement. https://youtu.be/KZ_NlnmPQYk?si=BleQF9-aReuttCU4 Reactions is a video series produced by the American Chemical Society and PBS Digital Studios. Subscribe to Reactions at http://bit.ly/ACSReactions ...

Prevalence of young children fed only breast milk in low- and middle-income countries

2024-02-12
About The Study: In this study of 276,000 children ages 6 to 23 months in 92 low- and middle-income countries, 10.4% were zero-food children (i.e., children who did not consume any animal milk, formula, or solid or semisolid food during the last 24 hours). The prevalence of zero-food children underscores the need for targeted interventions to improve infant and young child feeding practices and ensure optimal nutrition during this critical period of development. The issue is particularly urgent in West and Central ...

Emergency department use disparities among transgender and cisgender Medicare beneficiaries

2024-02-12
About The Study: The results of this study suggested that transgender and gender-diverse Medicare beneficiaries use significantly more emergency department services than cisgender beneficiaries, particularly for psychological care, and these visits were more likely to be followed by an admission. This study quantifies this excess use of emergent services and highlights upstream implications of delays in seeking timely health care.  Authors: Gray Babbs, M.P.H., of the Brown University School of Public Health in Providence, Rhode Island, is the corresponding author. To access the embargoed study: Visit our ...

Foster care involvement among youth with intellectual and developmental disabilities

2024-02-12
About The Study: This study found that among youth with intellectual and developmental disabilities, Black youth and females faced higher risk for foster care involvement, and the likelihood of foster care involvement increased with age. There is an urgent need for research that focuses on addressing system-level factors that drive increased risk. Understanding the specific health needs of Black and female youth with intellectual and developmental disabilities is critical to ensure the formation, ...

Groundbreaking study on decomposing microbes could help transform forensic science

2024-02-12
EMBARGO:  THIS CONTENT IS UNDER EMBARGO UNTIL 11 A.M. U.S. EASTERN STANDARD TIME ON FEBRUARY 12. INTERESTED MEDIA MAY RECIVE A PREVIEW COPY OF THE JOURNAL ARTICLE IN ADVANCE OF THAT DATE OR CONDUCT INTERVIEWS, BUT THE INFORMATION MAY NOT BE PUBLISHED, BROADCAST, OR POSTED ONLINE UNTIL AFTER THE RELEASE WINDOW. For the first time, researchers have identified what appears to be a network of approximately 20 microbes that universally drive the decomposition of animal flesh. The findings have significant implications for the future of forensic science, including ...

Under embargo: Risk of death 12% higher for non-White children in England

2024-02-12
Peer reviewed: Yes Type of evidence: Observational study Subject: People UNDER STRICT EMBARGO 16.00 hours [UK GMT] Monday 12 February 2024 / 11.00 hours [US EST] Monday 12 February 2024 Risk of death 12% higher for non-White children in England Twelve percent of infant deaths in England could be avoided if all infants in England had the same risk of death as White infants, a new University of Bristol-led study shows.  Such a change, which equates to more than 200 deaths per year, would bring England – which currently has one ...

Newly discovered brain cells play a key role in right and left turns

2024-02-12
Have you ever wondered what happens in the brain when we move to the right or left? Most people don’t; they just do it without thinking about it. But this simple movement is actually controlled by a complex process.  In a new study, researchers have discovered the missing piece in the complex nerve-network needed for left-right turns. The discovery was made by a research team consisting of Assistant Professor Jared Cregg, Professor Ole Kiehn, and their colleagues from the Department of Neuroscience at the University of Copenhagen.  In 2020, Ole Kiehn, Jared Cregg and their colleagues identified the ‘brain’s steering wheel’ – a network ...

Hevolution announces 49 awards to catalyze discovery in healthspan science through innovative $115 million grants program

Hevolution announces 49 awards to catalyze discovery in healthspan science through innovative $115 million grants program
2024-02-12
RIYADH, Saudi Arabia — February 12, 2024 — Hevolution Foundation, a global nonprofit organization that provides grants and early-stage investments to incentivize research and entrepreneurship in healthspan science, is announcing 49 new awards under its pioneering Hevolution Foundation - Geroscience Research Opportunities (HF-GRO) program.   As part of Hevolution’s mission to catalyze the healthspan scientific ecosystem and drive transformative breakthroughs in healthy aging, HF-GRO is funding promising pre-clinical research ...

Exposing hiding lymphoma cells to the immune system

2024-02-12
A study led by the group of Didier Trono at EPFL has revealed a crucial survival tactic employed by cancer cells. The scientists have identified a group of proteins, known as “KRAB zinc finger proteins” (KZFPs), that help cancer cells maintain genetic stability and avoid immune system detection. The study is published in Cancer Research. KZFPs are like managers inside our cells, helping to control which parts of our DNA are switched on or off. For example, some KZFPs interact with transposable elements, which ...

LAST 30 PRESS RELEASES:

Detection of suicide-related emergencies among children using real-world clinical data: A free webinar from the Brain & Behavior Research Foundation

Editor-in-Chief of Sustainability and Climate Change Madhavi Venkatesan named USA TODAY Woman of the Year for Massachusetts for leading plastic bottle ban efforts

Tests show high-temperature superconducting magnets are ready for fusion

Zika vaccine safe, effective when administered during pregnancy

Firearm ownership is correlated with elevated lead levels in children, study finds

Role of African women and young people in agricultural service provision investigated in new CABI-led study

26th International Conference of the Redox Medicine Society Set for June 2024 in Paris, France

Geologists explore the hidden history of Colorado’s Spanish Peaks

Webb unlocks secrets of one of the most distant galaxies ever seen

3D-printed skin closes wounds and contains hair follicle precursors

Discovered a RNA molecule that helps prevent DNA replication errors

Small and overlooked: Amount of repetitive DNA in blood hints at cancer early

Study determines the original orientations of rocks drilled on Mars

Illinois study: Supporting disease-challenged broiler chickens through nutrition

Communities severed by roads and traffic experience a larger number of collisions in New York City

Study shows new class of antivirals that works against SARS-CoV-2

Cost of direct air carbon capture to remain higher than hoped

Unraveling the mystery of chiton visual systems

Case Western Reserve University-led research team discovers new method to test for oral cancer

Firearm access and gun violence exposure are common in Black and native communities

New AI smartphone tool accurately diagnoses ear infections

Screen time and parent-child talk when children are ages 12 to 36 months

Firearm access and gun violence exposure among American Indian or Alaska native and Black adults

Associations of medical debt with health status, premature death, and mortality in the US

Low-cost liquid tames tooth decay

More than 1/3 illicit drugs sold on the dark web contain unexpected substances

A better way to deliver fetal therapy for serious genetic disorders

Researchers develop amphibian-inspired camouflage skin

Network of quantum sensors boosts precision

Robotic hip exoskeleton shows promise for helping stroke patients regain their stride

[Press-News.org] Novel bispecific design improves CAR T–cell immunotherapy for childhood leukemia
Scientists at St. Jude Children’s Research Hospital improved bispecific chimeric antigen receptor (CAR) T–cell immunotherapies for acute myeloid leukemia (AML), corroborated by computational analysis